Can elevated uric acid indicate insulin resistance and fatty liver disease?

The association between elevated serum uric acid (SUA) and metabolic dysfunction is well-documented, moving beyond its traditional role in gout to serve as a significant marker of metabolic syndrome, insulin resistance (IR), and nonalcoholic fatty liver disease (NAFLD), recently renamed metabolic dysfunction-associated steatotic liver disease (MASLD).

Clinical and epidemiological evidence

Research indicates that hyperuricemia is a robust, independent predictor of both insulin resistance and liver fat accumulation.

• Insulin Resistance: Higher SUA levels correlate significantly with IR markers such as the triglyceride-glucose (TyG) index and the metabolic score for insulin resistance (METS-IR). In patients with type 2 diabetes, the TyG index acts as an independent risk factor for elevated uric acid, suggesting a reciprocal relationship where IR and uric acid metabolism exacerbate each other.
• NAFLD/MASLD: Prospective cohort studies demonstrate that individuals in the highest quartile of SUA have a significantly increased risk of developing NAFLD, with odds ratios reaching 2.81 compared to the lowest quartile. Clinical data show that patients with NAFLD often exhibit markedly higher SUA levels (e.g., 6.9 mg/dL) than healthy controls (4.3 mg/dL).

Mechanistic explanations

The link between uric acid and hepatic health is fundamentally tied to cellular energy status and the purine degradation pathway.

• ATP Depletion: Rapid hepatic metabolism of certain substrates, particularly fructose, leads to a surge in phosphorylation that consumes ATP faster than it can be regenerated. This causes a transient depletion of hepatic ATP and inorganic phosphate.
• Purine Breakdown: As ATP levels fall, adenosine monophosphate (AMP) accumulates, activating AMP deaminase. This initiates the catabolic breakdown of purines into inosine and hypoxanthine, which are ultimately oxidized by xanthine oxidase into uric acid.
• Metabolic Signaling: This cascade identifies elevated uric acid as a sensitive biomarker for hepatic energy stress and compromised adenylate energy charge.

Bottom line

Elevated uric acid is a validated indicator of both insulin resistance and NAFLD, reflecting underlying hepatic ATP depletion and accelerated purine catabolism. Monitoring SUA can provide clinical insight into hepatic metabolic stress and systemic insulin sensitivity.